"We are interested in novel platforms for different nucleic acid based diagnostic applications," Mohammad Naraghi, senior vice president of business development at Siemens Medical Solutions, said in a statement. He said the MassArray technology "may be a good foundation" for the molecular diagnostics market.
As part of a "joint working group" the companies created for this collaboration, Siemens will install the four systems in certain diagnostics and clinical labs in
"There is a huge potential for innovation in diagnostics and IT systems," Erich Reinhardt, president and CEO of Siemens Medical Solutions, said in the statement. "Molecular medicine will have a significant impact on these platform developments."
Financial details of the collaboration were not disclosed.